{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:17:37Z","timestamp":1788401857367,"version":"build-2803163510"},"reference-count":131,"publisher":"American Chemical Society (ACS)","issue":"1","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Commission","doi-asserted-by":"publisher","award":["POWR.03.02.00-00-I009\/17"],"award-info":[{"award-number":["POWR.03.02.00-00-I009\/17"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005632","name":"Ministerstwo Nauki i Szkolnictwa Wyzszego","doi-asserted-by":"publisher","award":["POWR.03.02.00-00-I009\/17"],"award-info":[{"award-number":["POWR.03.02.00-00-I009\/17"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Methotrexate is a gold standard among disease modifying antirheumatic drugs and is also extensively used clinically in combination with oncological therapies. Thus, it is not surprising that nuclear medicine found an interest in methotrexate in the search for diagnostic and therapeutic solutions. Numerous folate-related radiopharmaceuticals have been proposed for nuclear medicine purposes; however, methotrexate radioagents represent only a minority. This imbalance results from the fact that methotrexate has significantly weaker affinity for folate receptors than folic acid. Nevertheless, radiolabeled methotrexate agents utilized as a tool for early detection and imaging of inflammation in rheumatoid arthritis patients gave promising results. Similarly, the use of multimodal MTX-release nanosystems may find potential applications in radiosynovectomy and theranostic approaches in folate receptor positive cancers.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.0c00740","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T07:52:36Z","timestamp":1606722756000},"page":"33-43","source":"Crossref","is-referenced-by-count":9,"title":["Perspectives of Methotrexate-Based Radioagents for\nApplication in Nuclear Medicine"],"prefix":"10.1021","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0657-3793","authenticated-orcid":true,"given":"Pawe\u0142 Krzysztof","family":"Halik","sequence":"first","affiliation":[{"name":"Institute of Nuclear Chemistry and Technology , , Dorodna 16 , ,","place":["Warsaw, Poland, 03-195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0471-6949","authenticated-orcid":true,"given":"Przemys\u0142aw","family":"Koz\u0301min\u0301ski","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Chemistry and Technology , , Dorodna 16 , ,","place":["Warsaw, Poland, 03-195"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gniazdowska","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Chemistry and Technology , , Dorodna 16 , ,","place":["Warsaw, Poland, 03-195"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"2026090221591405600_cit1","first-page":"539","article-title":"Experiments\nwith pteroylglutamic acid and pteroylglutamic acid deficiency in human\nleukemia","volume":"27","author":"Heinle","year":"1948","journal-title":"J. Clin. Invest."},{"key":"2026090221591405600_cit2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1182\/blood.V4.2.160.160","article-title":"Some observations\non the effect of folic acid antagonists on acute leukemia and other\nforms of incurable cancer","volume":"4","author":"Farber","year":"1949","journal-title":"Blood"},{"key":"2026090221591405600_cit3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood.V4.2.168.168","article-title":"The Use of\nFolic Acid Antagonists in the Treatment of Acute And Subacute Leukemia:\nA Preliminary Statement","volume":"4","author":"Dameshek","year":"1949","journal-title":"Blood"},{"key":"2026090221591405600_cit4","unstructured":"Methotrexate Injection FDA PI.\n          \n          https:\/\/www.drugs.com\/pro\/methotrexate-injection.html (accessed February 01, 2020)."},{"key":"2026090221591405600_cit5","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.3390\/ijms21103483","article-title":"Overview of\ndual-acting drug methotrexate in different neurological diseases,\nautoimmune pathologies and cancers","volume":"21","author":"Koz\u0301min\u0301ski","year":"2020","journal-title":"Int. J.\nMol. Sci."},{"key":"2026090221591405600_cit6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid\narthritis with synthetic and biological disease-modifying antirheumatic\ndrugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"2026090221591405600_cit7","doi-asserted-by":"publisher","first-page":"CD012722","DOI":"10.1002\/14651858.CD012722.pub2","article-title":"Methotrexate for\npsoriatic arthritis","volume":"1","author":"Wilsdon","year":"2019","journal-title":"Cochrane Database Syst.\nRev."},{"key":"2026090221591405600_cit8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0006-291X(73)90949-2","article-title":"Polygammaglutamyl metabolites of\nmethotrexate","volume":"52","author":"Baugh","year":"1973","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026090221591405600_cit9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1172\/JCI110624","article-title":"Synthesis,\nretention, and biological activity of methotrexate polyglutamates\nin cultured human breast cancer cells","volume":"70","author":"Jolivet","year":"1982","journal-title":"J. Clin.\nInvest."},{"key":"2026090221591405600_cit10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1172\/JCI112088","article-title":"Polyglutamation\nof methotrexate: is methotrexate a prodrug?","volume":"76","author":"Chabner","year":"1985","journal-title":"J. Clin. Invest."},{"key":"2026090221591405600_cit11","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1073\/pnas.82.15.4881","article-title":"Inhibition of phosphoribosylaminoimidazolecarboxamide\ntransformylase by methotrexate and dihydrofolic acid polyglutamates","volume":"82","author":"Allegra","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090221591405600_cit12","doi-asserted-by":"crossref","first-page":"9720","DOI":"10.1016\/S0021-9258(17)39298-0","article-title":"Enhanced\ninhibition\nof thymidylate synthase by methotrexate polyglutamates","volume":"260","author":"Allegra","year":"1985","journal-title":"J. Biol. Chem."},{"key":"2026090221591405600_cit13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/bj2360193","article-title":"Inhibition of 5-aminoimidazole4-carboxamide\nribotide transformylase, adenosine deaminase and 5\u2032-adenylate\ndeaminase by polyglutamates of methotrexate and oxidized folates and\nby 5-aminoimidazole-4-carboxamide riboside and ribotide","volume":"236","author":"Baggott","year":"1986","journal-title":"Biochem. J."},{"key":"2026090221591405600_cit14","first-page":"11038","article-title":"Antifolates\nInduce Inhibition of Amido Phosphoribosyltransferase in Leukemia","volume":"267","author":"Sant","year":"1992","journal-title":"Cell. J. Biol. Chem."},{"key":"2026090221591405600_cit15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1172\/JCI2676","article-title":"Immunosuppressive properties of methotrexate:\napoptosis\nand clonal deletion of activated peripheral T cells","volume":"102","author":"Genestier","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2026090221591405600_cit16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/bj3420143","article-title":"Methotrexate inhibits the first committed step of purine\nbiosynthesis in mitogen stimulated human T-lymphocytes: a metabolic\nbasis for efficacy in rheumatoid arthritis?","volume":"342","author":"Fairbanks","year":"1999","journal-title":"Biochem. J."},{"key":"2026090221591405600_cit17","first-page":"1506","article-title":"Purineless\nDeath as a Link Between Growth Rate and Cytotoxicity by Methotrexate","volume":"32","author":"Hryniuk","year":"1972","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1382-6689(00)00041-7","article-title":"Cytogenetic Toxicity of Methotrexate\nin Mouse Bone Marrow","volume":"8","author":"Choudhury","year":"2000","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"2026090221591405600_cit19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/bj2360193","article-title":"Inhibition\nof 5-aminoimidazole4-carboxamide\nribotide transformylase, adenosine deaminase and 5\u2032-adenylate\ndeaminase by polyglutamates of methotrexate and oxidized folates and\nby 5-aminoimidazole-4-carboxamide riboside and ribotide","volume":"236","author":"Baggott","year":"1986","journal-title":"Biochem. J."},{"key":"2026090221591405600_cit20","doi-asserted-by":"publisher","DOI":"10.32545\/encyclopedia202005.0014.v2","article-title":"Methotrexate\u2500Mechanisms\nof Drug Action","author":"Koz\u0301min\u0301ski","year":"2020","journal-title":"Encyclopedia"},{"key":"2026090221591405600_cit21","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory\nmechanism of\nmethotrexate: increased adenosine release at inflamed sites diminishes\nleukocyte accumulation in an in vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"1","key":"2026090221591405600_cit22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1476-5381.2010.00667.x","article-title":"Expression\nand Functional Role of Adenosine Receptors in Regulating Inflammatory\nResponses in Human Synoviocytes","volume":"160","author":"Varani","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"2026090221591405600_cit23","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar3871","article-title":"Adenosine receptor expression in rheumatoid synovium:\na basis for methotrexate action","volume":"14","author":"Stamp","year":"2012","journal-title":"Arthritis Res.\nTher."},{"key":"2026090221591405600_cit24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1172\/JCI112638","article-title":"Adenosine: an endogenous inhibitor\nof neutrophil-mediated\ninjury to endothelial cells","volume":"78","author":"Cronstein","year":"1986","journal-title":"J. Clin. Invest."},{"key":"2026090221591405600_cit25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled\nadenosine receptors in downregulation\nof inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"2026090221591405600_cit26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/1529-0131(199801)41:1&lt;48::AID-ART7&gt;3.0.CO;2-K","article-title":"Antiinflammatory and immunoregulatory action of methotrexate\nin the treatment of rheumatoid arthritis: Evidence of increased interleukin-4\nand interleukin-10 gene expression demonstrated in vitro by competitive\nreverse transcriptase-polymerase chain reaction","volume":"41","author":"Constantin","year":"1998","journal-title":"Arthritis Rheum."},{"key":"2026090221591405600_cit27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cell.2006.09.041","article-title":"Identification of\nan Intestinal Folate Transporter\nand the Molecular Basis for Hereditary Folate Malabsorption","volume":"127","author":"Qiu","year":"2006","journal-title":"Cell"},{"key":"2026090221591405600_cit28","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1124\/mol.108.045443","article-title":"The proton-coupled\nfolate transporter: impact on pemetrexed transport and on antifolates\nactivities compared with the reduced folate carrier","volume":"74","author":"Zhao","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"2026090221591405600_cit29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.mam.2012.07.006","article-title":"Folate and thiamine transporters mediated by facilitative\ncarriers (SLC19A1\u20133 and SLC46A1) and folate receptors","volume":"34","author":"Zhao","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"2026090221591405600_cit30","first-page":"4732","article-title":"Extent of the\nRequirement for Folate Transport by L1210 Cells for Growth and Leukemogenesis\nin Vivo","volume":"45","author":"Sirotnak","year":"1985","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0026-895X(25)10494-X","article-title":"Carrier- and receptor-mediated\ntransport of folate antagonists targeting folate-dependent enzymes:\ncorrelates of molecular-structure and biological activity","volume":"48","author":"Westerhof","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"2026090221591405600_cit32","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.1038\/sj.onc.1206946","article-title":"Resistance to antifolates","volume":"22","author":"Zhao","year":"2003","journal-title":"Oncogene"},{"key":"2026090221591405600_cit33","doi-asserted-by":"publisher","first-page":"15180","DOI":"10.1073\/pnas.1308827110","article-title":"Structures\nof human folate receptors reveal biological trafficking states and\ndiversity in folate and antifolate recognition","volume":"110","author":"Wibowo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090221591405600_cit34","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/0006-2952(92)90089-2","article-title":"Differential\nstereospecificities and affinities of folate receptor isoforms for\nfolate compounds and antifolates","volume":"44","author":"Xin","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"2026090221591405600_cit35","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.1074\/jbc.270.14.7842","article-title":"Distinguishing between\nfolate receptor-alpha-mediated transport and reduced folate carrier-mediated\ntransport in L1210 leukemia cells","volume":"270","author":"Spinella","year":"1995","journal-title":"J. Biol.\nChem."},{"key":"2026090221591405600_cit36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature12327","article-title":"Structural basis for\nmolecular recognition of folic acid by folate receptors","volume":"500","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"2026090221591405600_cit37","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1021\/bi00016a042","article-title":"Folate receptor type\ngamma is primarily a secretory protein due to lack of an efficient\nsignal for glycosylphosphatidylinositol modification: Protein characterization\nand cell type specificity","volume":"34","author":"Shen","year":"1995","journal-title":"Biochemistry"},{"key":"2026090221591405600_cit38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0378-1119(00)00418-2","article-title":"Identification\nof two putative novel\nfolate receptor genes in humans and mouse","volume":"258","author":"Spiegelstein","year":"2000","journal-title":"Gene"},{"key":"2026090221591405600_cit39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature13203","article-title":"Juno\nis the egg Izumo receptor and is essential for mammalian fertilisation","volume":"508","author":"Sanger Mouse Genetics Project.","year":"2014","journal-title":"Nature"},{"key":"2026090221591405600_cit40","first-page":"3396","article-title":"Distribution of the folate receptor GP38 in normal and malignant\ncell lines and tissues","volume":"52","author":"Weitman","year":"1992","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit41","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ijc.22811","article-title":"Folate\nreceptor overexpression is associated with poor outcome in breast\ncancer","volume":"121","author":"Hartmann","year":"2007","journal-title":"Int. J. Cancer"},{"key":"2026090221591405600_cit42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF01052894","article-title":"The folate\nreceptor in central nervous\nsystem malignancies of childhood","volume":"21","author":"Weitman","year":"1994","journal-title":"J. Neuro-Oncol."},{"key":"2026090221591405600_cit43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0959-8049(94)90257-7","article-title":"Folate binding protein\ndistribution in normal tissues and biological fluids from ovarian\ncarcinoma patients as detected by the monoclonal antibodies MOv18\nand MOv19","volume":"30","author":"Mantovani","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"2026090221591405600_cit44","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9&lt;2432::AID-CNCR2820730929&gt;3.0.CO;2-S","article-title":"Differential regulation of folate\nreceptor isoforms in normal and malignant tissues in vivo and in established\ncell lines: physiologic and clinical implications","volume":"73","author":"Ross","year":"1994","journal-title":"Cancer"},{"key":"2026090221591405600_cit45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/A:1027313502270","article-title":"Folate\nreceptors in malignant and benign tissues of human female genital\ntract","volume":"17","author":"Holm","year":"1997","journal-title":"Biosci. Rep."},{"key":"2026090221591405600_cit46","first-page":"775","article-title":"Expression\nof\nfolate receptor type a in relation to cell type, malignancy, and differentiation\nin ovary, uterus and cervix","volume":"8","author":"Wu","year":"1999","journal-title":"Cancer Epidemiol.\nBiomarkers Prev."},{"key":"2026090221591405600_cit47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1067\/mtc.2001.111176","article-title":"The alpha\nfolate receptor is highly activated in malignant pleural mesothelioma","volume":"121","author":"Bueno","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"2026090221591405600_cit48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor\nexpression in carcinomas and normal\ntissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal. Biochem."},{"key":"2026090221591405600_cit49","first-page":"6708","article-title":"Cellular localization\nof the folate receptor: potential role in drug toxicity and folate\nhomeostasis","volume":"52","author":"Weitman","year":"1992","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/ki.1992.7","article-title":"A high-affinity folate\nbinding-protein in proximal tubule cells of human kidney","volume":"41","author":"Holm","year":"1992","journal-title":"Kidney Int."},{"key":"2026090221591405600_cit51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1023\/a:1005713115147","article-title":"Folate receptors\nas potential therapeutic targets in choroid plexus tumors of SV40\ntransgenic mice","volume":"32","author":"Patrick","year":"1997","journal-title":"J. Neurooncol."},{"key":"2026090221591405600_cit52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1021\/bc9701297","article-title":"Design and Synthesis of [111In]DTPA-Folate\nfor Use as a Tumor-Targeted Radiopharmaceutical","volume":"8","author":"Wang","year":"1997","journal-title":"Bioconjugate Chem."},{"key":"2026090221591405600_cit53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1021\/bc9901447","article-title":"Synthesis of [99mTc]DTPA-Folate\nand Its Evaluation as a Folate-Receptor-Targeted Radiopharmaceutical","volume":"11","author":"Mathias","year":"2000","journal-title":"Bioconjugate Chem."},{"key":"2026090221591405600_cit54","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/1529-0131(199908)42:8&lt;1609::AID-ANR7&gt;3.0.CO;2-L","article-title":"Selective\nexpression of folate receptor beta and its possible role in methotrexate\ntransport in synovial macrophages from patients with rheumatoid arthritis","volume":"42","author":"Nakashima-Matsushita","year":"1999","journal-title":"Arthritis Rheum."},{"key":"2026090221591405600_cit55","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2&lt;348::AID-CNCR12&gt;3.0.CO;2-4","article-title":"Folate receptor\ntype beta is a neutrophilic\nlineage marker and is differentially expressed in myeloid leukemia","volume":"85","author":"Ross","year":"1999","journal-title":"Cancer"},{"key":"2026090221591405600_cit56","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1182\/blood-2014-11-612721","article-title":"Targeting of folate\nreceptor b on acute myeloid leukemia blasts with chimeric antigen\nreceptor-expressing T cells","volume":"125","author":"Lynn","year":"2015","journal-title":"Blood"},{"key":"2026090221591405600_cit57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2&lt;193::AID-IJC10&gt;3.0.CO;2-F","article-title":"Overexpression of folate\nbinding protein in ovarian\ncancers","volume":"74","author":"Toffoli","year":"1997","journal-title":"Int. J. Cancer"},{"key":"2026090221591405600_cit58","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1245\/s10434-007-9755-3","article-title":"Expression status of\nfolate receptor alpha is significantly\ncorrelated with prognosis in non-small-cell lung cancers","volume":"15","author":"Iwakiri","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"2026090221591405600_cit59","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/modpathol.2011.82","article-title":"Folate receptor-\u03b1\nexpression in resectable hepatic colorectal cancer metastases: patterns\nand significance","volume":"24","author":"D\u2019Angelica","year":"2011","journal-title":"Mod. Pathol."},{"key":"2026090221591405600_cit60","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.1158\/0008-5472.CAN-09-2050","article-title":"Folate Receptor \u03b2 Is Expressed by Tumor-Associated\nMacrophages and Constitutes a Marker for M2 Anti-inflammatory\/ Regulatory\nMacrophages","volume":"69","author":"Puig-Kro\u0308ger","year":"2009","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit61","doi-asserted-by":"publisher","first-page":"11086","DOI":"10.1074\/jbc.274.16.11086","article-title":"Complete mapping of\ndivergent amino acids responsible for differential ligand binding\nof folate receptors alpha and beta","volume":"274","author":"Maziarz","year":"1999","journal-title":"J. Biol.\nChem."},{"key":"2026090221591405600_cit62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.immuni.2007.04.017","article-title":"Control of Immune Responses by Antigen-Specific\nRegulatory T Cells Expressing the Folate Receptor","volume":"27","author":"Yamaguchi","year":"2007","journal-title":"Immunity"},{"key":"2026090221591405600_cit63","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/17425247.5.3.309","article-title":"Targeted drug delivery\nvia folate receptors","volume":"5","author":"Zhao","year":"2008","journal-title":"Expert Opin. Drug Delivery"},{"key":"2026090221591405600_cit64","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3390\/ijms16011772","article-title":"Mechanisms and Implications\nof Dual-Acting Methotrexate\nin Folate-Targeted Nanotherapeutic Delivery","volume":"16","author":"Wong","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"2026090221591405600_cit65","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.1021\/acs.biochem.8b00607","article-title":"Internalization of Methotrexate Conjugates by Folate\nReceptor-\u03b1","volume":"57","author":"Nogueira","year":"2018","journal-title":"Biochemistry"},{"key":"2026090221591405600_cit66","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2174\/138161212799315777","article-title":"Folate based\nradiopharmaceuticals for imaging and therapy of cancer and inflammation","volume":"18","author":"Mu\u0308ller","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"2026090221591405600_cit67","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.3390\/molecules18055005","article-title":"Folate-based\nradiotracers for PET imaging-update and perspectives","volume":"18","author":"Mu\u0308ller","year":"2013","journal-title":"Molecules"},{"key":"2026090221591405600_cit68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(79)90569-5","article-title":"Radiolabelled Methotrexate: A Warning","volume":"313","author":"Calvert","year":"1979","journal-title":"Lancet"},{"key":"2026090221591405600_cit69","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1016\/S0021-9258(18)91984-8","article-title":"Carrier-mediated\ntransport of the folic acid analogue, methotrexate, in the L1210 leukemia\ncell","volume":"243","author":"Goldman","year":"1968","journal-title":"J. Biol. Chem."},{"key":"2026090221591405600_cit70","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1016\/S0021-9258(19)85689-2","article-title":"Effect of [3H]methotrexate\nimpurities on apparent transport of methotrexate by a sensitive and\nresistant L1210 cell line","volume":"255","author":"Kamen","year":"1980","journal-title":"J. Biol. Chem."},{"key":"2026090221591405600_cit71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF01871067","article-title":"Interaction\nBetween Anions and the\nReduced Folate\/Methotrexate Transport System in L1210 Cell Plasma\nMembrane Vesicles: Directional Symmetry and Anion Specificity for\nDifferential Mobility of Loaded and Unloaded Carrier","volume":"79","author":"Yang","year":"1984","journal-title":"J. Membr. Biol."},{"key":"2026090221591405600_cit72","first-page":"1092","article-title":"[3H]Methotrexate\nLoss from the Rat Brain following Enhanced Uptake by Osmotic Opening\nof the Blood-Brain Barrier","volume":"45","author":"Ohata","year":"1985","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit73","first-page":"1008","article-title":"The Metabolic\nFate of Tritiated Methotrexate I. Absorption, Excretion, and Distribution\nin Mice, Rats, Dogs and Monkeys","volume":"25","author":"Henderson","year":"1965","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit74","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1172\/JCI108308","article-title":"7-Hydroxymethotrexate\nas a urinary metabolite in human subjects and rhesus monkeys receiving\nhigh dose methotrexate","volume":"57","author":"Jacobs","year":"1976","journal-title":"J. Clin. Invest."},{"key":"2026090221591405600_cit75","first-page":"1018","article-title":"The Metabolic\nFate of Tritiated Methotrexate II. Absorption and Excretion in Man","volume":"25","author":"Henderson","year":"1965","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit76","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF01061726","article-title":"A Pharmacokinetic Model\nfor High-Dose Methotrexate Infusions in Man","volume":"5","author":"Reich","year":"1977","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"2026090221591405600_cit77","first-page":"1647","article-title":"Some observations\non the human pharmacology of methotrexate","volume":"61","author":"Calvert","year":"1977","journal-title":"Cancer Treat. Rep."},{"key":"2026090221591405600_cit78","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0009-8981(74)90406-9","article-title":"Radioimmunoassay of methotrexate\nin biological fluids","volume":"57","author":"Bohuon","year":"1974","journal-title":"Clin. Chim. Acta"},{"key":"2026090221591405600_cit79","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/bjc.1977.238","article-title":"Development\nand application of a\nradioimmunoassay for methotrexate","volume":"36","author":"Aherne","year":"1977","journal-title":"Br. J. Cancer"},{"key":"2026090221591405600_cit80","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/000456327801500179","article-title":"Radioimmunoassay\nof methotrexate:\nuse of 75Se-labelled methotrexate","volume":"15","author":"Aherne","year":"1978","journal-title":"Ann. Clin.\nBiochem."},{"key":"2026090221591405600_cit81","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/clinchem\/24.9.1534","article-title":"Comparison of three radioligands,\nselenium-75, iodine-125, and tritium, in the radioimmunoassay of methotrexate","volume":"24","author":"Paxton","year":"1978","journal-title":"Clin. Chem."},{"key":"2026090221591405600_cit82","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.ejca.2004.06.024","article-title":"Methotrexate\ninhibits\nthe glyoxalase system in vivo in children with acute lymphoid leukaemia","volume":"40","author":"Bartyik","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"2026090221591405600_cit83","first-page":"3795","article-title":"Functional\nActivity\nof the Reduced Folate Carrier in KB, MA104, and IGROV-I Cells Expressing\nFolate-Binding Protein","volume":"55","author":"Westerhof","year":"1995","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit84","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1158\/1078-0432.CCR-04-0645","article-title":"Characterization\nof a Folate Transporter\nin HeLa Cells with a Low pH Optimum and High Affinity for Pemetrexed\nDistinct from the Reduced Folate Carrier","volume":"10","author":"Wang","year":"2004","journal-title":"Clin.\nCancer Res."},{"key":"2026090221591405600_cit85","first-page":"6434","article-title":"A Novel Folate Transport Activity\nin Human Mesothelioma Cell Lines with High Affinity and Specificity\nfor the New-Generation Antifolate, Pemetrexed","volume":"62","author":"Wang","year":"2002","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit86","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00280-008-0683-0","article-title":"Dynamics of antifolate\ntransport via the reduced folate carrier and the membrane folate receptor\nin murine leukaemia cells in vitro and in vivo","volume":"62","author":"Mauritz","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2026090221591405600_cit87","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00280-009-0954-4","article-title":"Distinct mechanistic\nactivity profile\nof pralatrexate in comparison to other antifolates in in vitro and\nin vivo models of human cancers","volume":"64","author":"Izbicka","year":"2009","journal-title":"Cancer Chemother.\nPharmacol."},{"key":"2026090221591405600_cit88","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/bjc.1992.178","article-title":"Monoclonal antibody targeting of methotrexate (MTX)\nagainst MTX-resistant tumour cell lines","volume":"65","author":"Affleck","year":"1992","journal-title":"Br.\nJ. Cancer"},{"key":"2026090221591405600_cit89","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0005-2736(76)90108-5","article-title":"Differential\ndistribution of liposome-entrapped [3H]methotrexate and labelled lipids\nafter intravenous injection in a primate","volume":"448","author":"Kimelberg","year":"1976","journal-title":"Biochim.\nBiophys. Acta, Biomembr."},{"key":"2026090221591405600_cit90","first-page":"706","article-title":"Distribution of\nfree and liposome-entrapped [3H]methotrexate in the central nervous\nsystem after intracerebroventricular injection in a primate","volume":"38","author":"Kimelberg","year":"1978","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0378-5173(93)90035-E","article-title":"Lymph node targeting and pharmacokinetics of [3H]methotrexate-encapsulated\nneutral large unilamellar vesicles and immunoliposomes","volume":"98","author":"Kim","year":"1993","journal-title":"Int. J. Pharm."},{"key":"2026090221591405600_cit92","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0378-5173(94)90412-X","article-title":"Pharmacokinetics\nand tissue distribution of methotrexate after intravenous injection\nof differently charged liposome-entrapped methotrexate to rats","volume":"108","author":"Kim","year":"1994","journal-title":"Int. J. Pharm."},{"key":"2026090221591405600_cit93","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/02652049509087256","article-title":"Lymphatic delivery and pharmacokinetics\nof methotrexate\nafter intramuscular injection of differently charged liposome-entrapped\nmethotrexate to rats","volume":"12","author":"Kim","year":"1995","journal-title":"J. Microencapsulation"},{"key":"2026090221591405600_cit94","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0168-3659(89)90020-5","article-title":"The intracellular release of methotrexate\nfrom a synthetic drug carrier system targeted to fc receptor-bearing\ncells","volume":"10","author":"Shen","year":"1989","journal-title":"J. Controlled Release"},{"key":"2026090221591405600_cit95","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1021\/bc00019a004","article-title":"Influence\nof carrier on biodistribution\nand in vitro cytotoxicity of methotrexate -branched polypeptide conjugates","volume":"4","author":"Hudecz","year":"1993","journal-title":"Bioconjugate Chem."},{"key":"2026090221591405600_cit96","first-page":"478","article-title":"Methotrexate-a-Phenylalanine:\nOptimization of Methotrexate Prodrug for Activation by Carboxypeptidase\nA-Monoclonal Antibody Conjugate","volume":"55","author":"Vitols","year":"1995","journal-title":"Cancer Res."},{"key":"2026090221591405600_cit97","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1073\/pnas.88.11.4771","article-title":"Anti-transferrin\nreceptor antibody and antibody-drug\nconjugates cross the blood-brain barrier","volume":"88","author":"Friden","year":"1991","journal-title":"Proc.\nNatl. Acad. Sci. U. S. A."},{"key":"2026090221591405600_cit98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00199293","article-title":"Target-selective cytotoxicity of\nmethotrexate conjugated with monoclonal anti-MM46 antibody","volume":"25","author":"Endo","year":"1987","journal-title":"Cancer Immunol. Immunother."},{"key":"2026090221591405600_cit99","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1016\/0006-2952(89)90007-5","article-title":"Selective delivery of drugs to macrophages\nthrough a highly specific receptor. An efficient chemotherapeutic\napproach against leishmaniasis","volume":"38","author":"Chaudhuri","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"2026090221591405600_cit100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0378-5173(99)00206-9","article-title":"Enhanced\nhepatocyte uptake and liver targeting of methotrexate using galactosylated\nalbumin as a carrier","volume":"188","author":"Han","year":"1999","journal-title":"Int. J. Pharm."},{"key":"2026090221591405600_cit101","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/107175401316906883","article-title":"Altered Pharmacokinetics\nand Liver Targetability of Methotrexate by Conjugation with Lactosylated\nAlbumins","volume":"8","author":"Han","year":"2001","journal-title":"Drug Delivery"},{"key":"2026090221591405600_cit102","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0378-5173(93)90109-S","article-title":"The organ\ntargetability\nof small and large albumin microspheres containing free and HSA conjugated\nmethotrexate","volume":"89","author":"Kim","year":"1993","journal-title":"Int. J. Pharm."},{"key":"2026090221591405600_cit103","first-page":"1917","article-title":"In Vitro and\nin Vivo Antitumor Activity of Methotrexate Conjugated to Human Serum\nAlbumin in Human Cancer Cells","volume":"9","author":"Wosikowski","year":"2003","journal-title":"Clin. Cancer\nRes."},{"key":"2026090221591405600_cit104","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00044-014-1172-0","article-title":"Development of reversible glutamine\nconjugate of methotrexate for enhanced brain delivery","volume":"24","author":"Singh","year":"2015","journal-title":"Med. Chem. Res."},{"key":"2026090221591405600_cit105","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3109\/10717544.2014.984369","article-title":"Development and characterization\nof lysine-methotrexate conjugate for enhanced brain delivery","volume":"23","author":"Singh","year":"2016","journal-title":"Drug Delivery"},{"key":"2026090221591405600_cit106","first-page":"507P","article-title":"Preparation and evaluation of Tc-99m-labeled folate\nand methotrexate analogs as tumor imaging agents","volume":"47","author":"Okarvi","year":"2006","journal-title":"J. Nucl. Med."},{"key":"2026090221591405600_cit107","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/cbr.2006.21.49","article-title":"Preparation and\nIn Vitro and In Vivo\nEvaluation of Technetium-99m-Labeled Folate and Methotrexate Conjugates\nas Tumor Imaging Agents","volume":"21","author":"Okarvi","year":"2006","journal-title":"Cancer Biother.Radiopharm."},{"key":"2026090221591405600_cit108","first-page":"1754","article-title":"Modified method\nfor methotrexate-Tc-99m labeled radiopharmaceutical, synthesis and\nevaluation","volume":"53","author":"Ahmed","year":"2012","journal-title":"J. Nucl. Med."},{"key":"2026090221591405600_cit109","first-page":"AJ22","article-title":"Radiolabeling, Biodistribution and\nTumor Imaging of Stealth Liposomes Containing Methotrexate","volume":"6","author":"Subramanian","year":"2003","journal-title":"Alasbimn J."},{"key":"2026090221591405600_cit110","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/cbr.2008.0497","article-title":"Polyethylene Glycol\nConjugates of Methotrexate and Melphalan: Synthesis, Radiolabeling\nand Biologic Studies","volume":"23","author":"Shukla","year":"2008","journal-title":"Cancer Biother.Radiopharm."},{"key":"2026090221591405600_cit111","first-page":"120","article-title":"Preparation and\nbiodistribution in\nmice of a new radiopharmaceutical-technetium-99m labeled methotrexate,\nas a tumor diagnostic agent","volume":"15","author":"Dar","year":"2012","journal-title":"Hell. J. Nucl.\nMed."},{"key":"2026090221591405600_cit112","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1967\/s002449910069","article-title":"Preparation\nof (99m)Tc-labelled methotraxate by a direct labeling technique as\na potential diagnostic agent for breast cancer and preliminary clinical\nresults","volume":"16","author":"Rasheed","year":"2013","journal-title":"Hell. J. Nucl. Med."},{"key":"2026090221591405600_cit113","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jddst.2015.10.004","article-title":"Methotrexate\nloaded chitosan nanoparticles: Preparation, radiolabeling and in vitro\nevaluation for breast cancer diagnosis","volume":"30","author":"Ekinci","year":"2015","journal-title":"J. Drug\nDelivery Sci. Technol."},{"key":"2026090221591405600_cit114","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10967-015-4210-6","article-title":"Radiolabeling and in vitro evaluation\nof 99mTc-methotrexate on breast cancer cell line","volume":"307","author":"Ozgenc","year":"2016","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"2026090221591405600_cit115","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/cbr.1998.13.177","article-title":"Imaging tumor folate receptors using\n111In-DTPA-methotrexate","volume":"13","author":"Ilgan","year":"1998","journal-title":"Cancer Biother. Radiopharm."},{"key":"2026090221591405600_cit116","first-page":"331P","article-title":"Biodistribution\nand imaging of Ga-68\nand Tc-99m-glycopeptide-methotrexate (GP-MTX) in rodents","volume":"49","author":"Tsao","year":"2008","journal-title":"J. Nucl. Med."},{"key":"2026090221591405600_cit117","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.nucmedbio.2009.12.006","article-title":"Synthesis\nand evaluation of a technetium-99m\nlabeled cytotoxic bombesin peptide conjugate for targeting bombesin\nreceptor-expressing tumors","volume":"37","author":"Okarvi","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"2026090221591405600_cit118","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.nucmedbio.2011.03.004","article-title":"Rapid synthesis\nand in vitro and in vivo evaluation of folic acid derivatives labeled\nwith fluorine-18 for PET imaging of folate receptor-positive tumors","volume":"38","author":"Jammaz","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"2026090221591405600_cit119","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.nucmedbio.2012.02.005","article-title":"Novel synthesis and\npreclinical evaluation of folic\nacid derivatives labeled with 18F-[FDG] for PET imaging of folate\nreceptor-positive tumors","volume":"39","author":"Al Jammaz","year":"2012","journal-title":"Nucl. Med. Biol."},{"key":"2026090221591405600_cit120","doi-asserted-by":"publisher","first-page":"BP99","DOI":"10.1007\/s00259-003-1347-2","article-title":"Bone scintigraphy:\nprocedure guidelines\nfor tumour imaging","volume":"30","author":"Bombardieri","year":"2003","journal-title":"Eur. J. Nucl. Med. Mol.\nImaging"},{"key":"2026090221591405600_cit121","first-page":"1356","article-title":"Imaging of malignant bone involvement\nby morphologic,\nscintigraphic, and hybrid modalities","volume":"46","author":"Even-Sapir","year":"2005","journal-title":"J. Nucl.\nMed."},{"key":"2026090221591405600_cit122","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.4172\/2327-5146.1000S213","article-title":"Tc99m Methotrexate\n(MTX) A Novel Complex for Imaging of Rheumatoid Arthritis (RA): First\nClinical Trials","author":"Rasheed","year":"2016","journal-title":"Gen. Med. (Los Angeles)"},{"key":"2026090221591405600_cit123","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3892\/mmr.2017.8166","article-title":"Radiolabeled\nmethotrexate as a diagnostic agent of inflammatory target sites: A\nproof-of-concept study","volume":"17","author":"Papachristou","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"2026090221591405600_cit124","first-page":"105","article-title":"Targeted Delivery\nof Antineoplastic Agent to Bone: Biodistribution Studies of Technetium-99m-Labeled\nGem-Bisphosphonate Conjugate of Methotrexate","volume":"37","author":"Hosain","year":"1996","journal-title":"J. Nucl. Med."},{"key":"2026090221591405600_cit125","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1189\/jlb.0613345","article-title":"Macrophage uptake and accumulation of folates are polarization-dependent\nin vitro and in vivo and are regulated by activin A","volume":"95","author":"Samaniego","year":"2014","journal-title":"J. Leukocyte Biol."},{"key":"2026090221591405600_cit126","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.4049\/jimmunol.1201064","article-title":"The prolyl\nhydroxylase PHD3 identifies proinflammatory macrophages\nand its expression is regulated by activin A","volume":"189","author":"Escribese","year":"2012","journal-title":"J. Immunol."},{"key":"2026090221591405600_cit127","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1136\/annrheumdis-2015-208736","article-title":"Methotrexate\nselectively targets human proinflammatory macrophages through a thymidylate\nsynthase\/p53 axis","volume":"75","author":"Municio","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"2026090221591405600_cit128","doi-asserted-by":"publisher","first-page":"109766","DOI":"10.1016\/j.msec.2019.109766","article-title":"Preparation\nand in vitro evaluation of radiolabeled\nHA-PLGA nanoparticles as novel MTX delivery system for local treatment\nof rheumatoid arthritis","volume":"103","author":"Trujillo-Nolasco","year":"2019","journal-title":"Mater. Sci. Eng. C.\nMater. Biol. Appl."},{"key":"2026090221591405600_cit129","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1021\/mp300701e","article-title":"Augmented\nAnticancer\nActivity of a Targeted, Intracellularly Activatable, Theranostic Nanomedicine\nBased on Fluorescent and Radiolabeled, Methotrexate-Folic Acid-Multiwalled\nCarbon Nanotube Conjugate","volume":"10","author":"Das","year":"2013","journal-title":"Mol. Pharmaceutics"},{"key":"2026090221591405600_cit130","doi-asserted-by":"publisher","first-page":"1910676","DOI":"10.1002\/adfm.201910676","article-title":"Nanomaterials for Combinational\nRadio\u2013Immuno\nOncotherapy","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"2026090221591405600_cit131","first-page":"2368","article-title":"Delivery\nof Radionuclides to Pretargeted Monoclonal Antibodies Using Dihydrofolate\nRedactase and Methotrexate in an Affinity System","volume":"53","author":"Hawkins","year":"1993","journal-title":"Cancer Res."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.0c00740","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/18\/1\/33\/67091735\/acs.molpharmaceut.0c00740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/18\/1\/33\/67091735\/acs.molpharmaceut.0c00740.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:59:26Z","timestamp":1788400766000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/18\/1\/33\/577604\/Perspectives-of-Methotrexate-Based-Radioagents-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,30]]},"published-print":{"date-parts":[[2021,1,4]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00740","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]}}}